ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
36.26
0.33%
US Tech 100
19,856.00
0.05%
S&P 500
5,631.22
0.28%
US Dollar vs CAD
1.36803
0.01%
Bitcoin
63,249.71
-2.47%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. ImmunoGen Inc (IMGN)

  7. ImmunoGen Inc (IMGN) News

IMGN

ImmunoGen (IMGN)

ImmunoGen Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:IMGN
DateTimeSourceHeadlineSymbolCompany
11/15/20223:52AMTipRanksImmunoGen (IMGN) Stock Rallying on FDA ApprovalNASDAQ:IMGNImmunoGen Inc
11/14/20224:53PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IMGNImmunoGen Inc
11/14/20224:20PMDow Jones NewsImmunoGen Shares Jump 8.9% on FDA Accelerated Approval of ElahereumpNASDAQ:IMGNImmunoGen Inc
11/14/20223:30PMBusiness WireImmunoGen Announces FDA Accelerated Approval of ELAHERE™ (mirvetuximab soravtansine-gynx) for the Treatment of Platinum-Resistant Ovarian CancerNASDAQ:IMGNImmunoGen Inc
11/07/20228:50AMTipRanksAnalysts Conflicted on These Healthcare Names: Eli Lilly & Co (LLY), ImmunoGen (IMGN) and Bausch Health Companies (BHC)NASDAQ:IMGNImmunoGen Inc
11/07/20225:15AMTipRanksH.C. Wainwright Sticks to Their Buy Rating for ImmunoGen (IMGN)NASDAQ:IMGNImmunoGen Inc
11/04/20228:48AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:IMGNImmunoGen Inc
11/04/20225:43AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IMGNImmunoGen Inc
11/04/20225:30AMBusiness WireImmunoGen Reports Recent Progress and Third Quarter 2022 Financial ResultsNASDAQ:IMGNImmunoGen Inc
11/02/20228:45AMTipRanksBMO Capital Sticks to Its Buy Rating for ImmunoGen (IMGN)NASDAQ:IMGNImmunoGen Inc
11/01/20223:30PMBusiness WireImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:IMGNImmunoGen Inc
11/01/20225:30AMBusiness WireImmunoGen Announces Departure of Chief Commercial OfficerNASDAQ:IMGNImmunoGen Inc
10/28/20227:40AMBusiness WireImmunoGen Presents Retrospective Analysis of Extended Treatment Benefit from Multiple Trials of Mirvetuximab Soravtansine in Ovarian Cancer at ESGONASDAQ:IMGNImmunoGen Inc
10/20/20223:01PMBusiness WireImmunoGen Announces Conference Call to Discuss Its Third Quarter 2022 Operating ResultsNASDAQ:IMGNImmunoGen Inc
10/04/20223:15PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
10/03/20223:30PMBusiness WireImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:IMGNImmunoGen Inc
09/29/20227:00AMBusiness WireImmunoGen Presents Comprehensive Updates for Mirvetuximab Soravtansine Combination Data in Ovarian Cancer at IGCSNASDAQ:IMGNImmunoGen Inc
09/14/20223:30PMBusiness WireImmunoGen Announces Webcast of Presentation and Q&A at Upcoming Guggenheim Nantucket Therapeutics ConferenceNASDAQ:IMGNImmunoGen Inc
09/11/20225:00AMBusiness WireImmunoGen Presents Additional Analyses Evaluating Mirvetuximab Soravtansine in Ovarian Cancer at ESMONASDAQ:IMGNImmunoGen Inc
09/06/20225:50AMTipRanksAnalysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY) and ImmunoGen (IMGN)NASDAQ:IMGNImmunoGen Inc
09/01/202210:16PMTipRanksImmunoGen (IMGN) Receives a Hold from SVB SecuritiesNASDAQ:IMGNImmunoGen Inc
09/01/20223:30PMBusiness WireImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:IMGNImmunoGen Inc
09/01/20225:15AMTipRanksImmunoGen (IMGN) Receives a Buy from H.C. WainwrightNASDAQ:IMGNImmunoGen Inc
08/31/20225:30AMBusiness WireImmunoGen Provides Update on Pivotal CADENZA Study of Pivekimab Sunirine in Frontline Blastic Plasmacytoid Dendritic Cell NeoplasmNASDAQ:IMGNImmunoGen Inc
08/02/20229:25PMTipRanksAnalysts Offer Insights on Healthcare Companies: Amedisys (AMED), Eli Lilly & Co (LLY) and ImmunoGen (IMGN)NASDAQ:IMGNImmunoGen Inc
08/01/20224:29PMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:IMGNImmunoGen Inc
08/01/20223:30PMBusiness WireImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:IMGNImmunoGen Inc
08/01/20223:08PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:IMGNImmunoGen Inc
08/01/20225:17AMTipRanksImmunoGen (IMGN) Gets a Buy Rating from H.C. WainwrightNASDAQ:IMGNImmunoGen Inc
07/29/20225:30AMBusiness WireImmunoGen Reports Recent Progress and Second Quarter 2022 Financial ResultsNASDAQ:IMGNImmunoGen Inc
 Showing the most relevant articles for your search:NASDAQ:IMGN

Your Recent History

USOTC
AXXA
Exxe (PK)
USOTC
MGON
Megola (PK)
NASDAQ
FFIE
Faraday Future Intellige...
USOTC
IQST
iQSTEL (QX)
USOTC
IGPK
Intergrated Cannabis Sol... (PK)
USOTC
RONN
Ronn Motor (PK)
USOTC
GRST
Ethema Health (PK)
USOTC
WDLF
Decentral Life (PK)
USOTC
FNMA
Fannie Mae (QB)
USOTC
BLEG
Branded Legacy (PK)
USOTC
UBQU
Ubiquitech Software (PK)
USOTC
TPTW
TPT Global Tech (PK)
USOTC
ENZC
Enzolytics (PK)
USOTC
IFUS
Impact Fusion (PK)
USOTC
RNVA
Rennova Health (PK)
USOTC
DBMM
Digital Brand Media and ... (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved